Plus   Neg

Momentum Stocks To Watch: Gilead Sciences Inc. (GILD)

Shares of Gilead Sciences Inc. (GILD) are rising, after the company said it is working with Chinese health authorities to test whether its experimental antiviral therapy - Remdesivir can work against the symptoms of coronavirus.

The biopharma said that Remdesivir has demonstrated in vitro and in vivo activity in animal models against the viral pathogens MERS and SARS, which are coronaviruses that are structurally similar to 2019-nCoV - the new viral strain responsible for the current catastrophe. For readers not familiar with medical jargon, In vitro is performing a given procedure in a controlled environment outside of a living organism, while in vivo studies are those conducted in living organisms. The company said it is expediting appropriate laboratory testing of remdesivir against 2019-nCoV samples.

Remdesivir is not yet licensed or approved anywhere globally and has not been demonstrated to be safe or effective for any use, the company further stated.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Lowe's (LOW) is temporarily increasing wages of its employees. The latest move by the hardware retailer is to help its employees cope with the economical effects caused by the ongoing COVID-19 pandemic. The company has hiked salary by $2 per hour for all full-time, part-time, and seasonal hourly associates,... Amazon.com Inc. (AMZN) Founder and CEO Jeff Bezos is donating $100 million to food banks across the U.S. to support poor people who cannot afford food during this coronavirus crisis. Bezos made a $100 million gift to Feeding America, one of the largest U.S. nonprofit focused on food security. Feeding... Facebook on Thursday shared an update on its $100 million small-business grants program announced in March, saying that it will provide $40 million in grants to 10,000 U.S. small businesses that were impacted by the coronavirus pandemic. In March, the social media giant said it is offering $100 million in cash grants and ad credits for up to 30,000 eligible small businesses.
Follow RTT